J&J's one-dose covid-19 vaccine candidate JNJ-78436735 begins phase III trial

The ENSEMBLE trial will evaluate safety and efficacy of a single dose compared to placebo in up to 60,000 adults ages 18 years and older. Unlike some other vaccine candidates, it can be stored at room temperature and only one dose is required compared to two doses ~28 days apart

Source:

Biospace Inc.